Thank you, Mr. Chair. I know this will come out of my time, but if we are going to get into those points of order, I could go back to any witness and be critical of a lack of government funding.
I know Mr. Lemieux is trying to put it on the record that there is government funding there, and that's fine. But if we get into that kind of game, we'll never get anything done.
Mr. Taylor, you mentioned that there is no independent testing. Mr. Black mentioned that there is no long-term testing by independent researchers.
I went back and looked at the rBGH hearings that we held in 1994, which is also an issue having to do with genetic modification. I want to submit that we're talking about biotechnology here, not exclusively GM. One thing we learned on our tour last week is that genetic modification, genetic engineering, is really a small part of the whole biotechnology industry. There are lot of good things happening with biotech in organic and regular breeding. And there is the GM aspect. One is not exclusively the other. That's what I'm saying.
In any event, what would you propose should be done there? I don't disagree with you that governments tend to look at the research of the companies. The data is peer-reviewed and analyzed by Health Canada and others. What would you suggest? Should there be a separate, independent research institute? Should it be within one country? Should it be global? What would you suggest?